BioSpace News Archive

Rhythm Pharmaceuticals, Inc. today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 2, 2022 to report its second quarter 2022 financial results and provide a corporate update.

Immutep Limited, a biotechnology company developing novel LAG-3-related immunotherapy treatments for cancer and autoimmune disease, provides an update on the ongoing development of its product candidates, eftilagimod alpha and IMP761 for the quarter ended 30 June 2022.

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a 2-year collaboration with Memorial Sloan Kettering Cancer Center (MSK) to develop new biosimulation software. Certara will be working with the MSK Innovation Hub to create a Chimeric antigen receptor (CAR) T-cell therapy biosimulation platform.

CytomX Therapeutics, Inc. today announced that it will report second quarter 2022 financial results on Thursday, August 4, 2022, after the close of U.S. markets.

Achieve Life Sciences, Inc. today announced it will report its second quarter financial results and provide an update on the cytisinicline development program on Thursday, August 11, 2022, at 4:30 PM EDT.

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that it will report financial results for the second quarter ended June 30, 2022, after the close of the market on Thursday, August 4, 2022.

Genetic Technologies Limited, a global leader in genomics-based tests in health, wellness and serious disease provides its cashflow results for the quarter ended June 30, 2022.

InnerScope Hearing Technologies Inc. (OTC: INND) (“InnerScope”), an emerging and disruptive leader in the Direct-to-Consumer Hearing Technology space, is pleased to announce today that its wholly-owned subsidiary HearingAssist has received $2,750,000 for its Receivable Factoring Agreement (“Factoring Agreement”) with Star Funding Inc. (“Star Funding”).

Seqster PDM, Inc. (“Seqster”), the leader in patient-centric healthcare data technology announced a 3-year partnership with Boehringer Ingelheim to connect the patients to all of their health data.

Eiger BioPharmaceuticals, Inc. today announced that it will host a conference call on Thursday, August 4, 2022 at 4:30 PM ET to discuss its second quarter 2022 financial results and provide a business update.